Last month, Britain’s National Health Service made major news when they announced that they were banning the use of puberty blockers for children, except for those enrolled in a tightly regulated clinical trial. The decision was made after an independent review found there were “significant uncertainties” surrounding the long-term effects of these drugs, which had previously been touted as totally reversible.
